Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies

Cervical cancer during pregnancy is relatively uncommon. However, the incidence is expected to increase as more women delay childbearing. When preservation of the pregnancy is desired, optimal treatment is a major challenge to all. Whereas delay of treatment is an option for pre-invasive disease, and also small invasive carcinomas without lymph node involvement, management of tumours >2 cm remains experimental. Type of treatment needs to be individualized and depends mainly on gestational age, disease stage, and histology. Extensive counselling regarding the maternal and foetal risks is required. In this current review, we aim to summarize available data and treatment guidelines concerning cervical cancer in pregnancy. Controversies and research priorities are also identified.

[1]  F. Amant,et al.  Is chemotherapy during the first trimester of pregnancy really safe? , 2013, International journal of cancer.

[2]  M. Zikan,et al.  Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial. , 2013, Gynecologic oncology.

[3]  F. Amant,et al.  Cancer in pregnancy: a survey of current clinical practice. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[4]  R. Bartsch,et al.  Platinum Derivatives During Pregnancy in Cervical Cancer: A Systematic Review and Meta-Analysis , 2013, Obstetrics and gynecology.

[5]  A. Kezouh,et al.  Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy , 2013, Archives of Gynecology and Obstetrics.

[6]  J. Tierney,et al.  Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. , 2012, The Cochrane database of systematic reviews.

[7]  Chengyu Shi,et al.  RADAR Reference Adult, Pediatric, and Pregnant Female Phantom Series for Internal and External Dosimetry , 2012, The Journal of Nuclear Medicine.

[8]  F. Amant,et al.  Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review , 2012, BMC Medicine.

[9]  C. Mangioni,et al.  Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review. , 2012, Gynecologic oncology.

[10]  K. Petry.  Lymphadenectomy for pregnant women with stage I cervical cancer , 2012, The Lancet.

[11]  C. Haie-meder,et al.  Gynaecological cancers in pregnancy , 2012, The Lancet.

[12]  L. Lagae,et al.  Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. , 2012, The Lancet. Oncology.

[13]  P. Terrier,et al.  Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy , 2012, Cancer Chemotherapy and Pharmacology.

[14]  P. Sundgren,et al.  Is administration of gadolinium‐based contrast media to pregnant women and small children justified? , 2011, Journal of magnetic resonance imaging : JMRI.

[15]  Alok R. Khandelwal,et al.  18F-FDG PET in Pregnancy and Fetal Radiation Dose Estimates , 2011, The Journal of Nuclear Medicine.

[16]  P. Ramirez,et al.  Conservative management of early stage cervical cancer: is there a role for less radical surgery? , 2011, Gynecologic oncology.

[17]  L. Rob,et al.  Fertility-sparing surgery in patients with cervical cancer. , 2011, The Lancet. Oncology.

[18]  F. Amant,et al.  Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study , 2010, Acta obstetricia et gynecologica Scandinavica.

[19]  C. Çelik,et al.  Radical trachelectomy in late pregnancy: is it an option? , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[20]  F. Amant,et al.  Gynaecologic cancer complicating pregnancy: an overview. , 2010, Best practice & research. Clinical obstetrics & gynaecology.

[21]  S. Pecorelli.  Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .

[22]  E. Darai,et al.  French Recommendations on the Management of Invasive Cervical Cancer During Pregnancy , 2009, International Journal of Gynecologic Cancer.

[23]  B. Apgar,et al.  Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. , 2009, American family physician.

[24]  M. Deavers,et al.  Parametrial Involvement in Radical Hysterectomy Specimens for Women With Early-Stage Cervical Cancer , 2009, Obstetrics and gynecology.

[25]  O. Mir,et al.  Gynecologic Cancers in Pregnancy: Guidelines of a Second International Consensus Meeting , 2009, International Journal of Gynecologic Cancer.

[26]  L. Lagae,et al.  Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting , 2009, International Journal of Gynecologic Cancer.

[27]  B. Monk,et al.  Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease. , 2008, American journal of obstetrics and gynecology.

[28]  M. Zikan,et al.  Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. , 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[29]  M. Sekine,et al.  Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy. , 2008, Gynecologic oncology.

[30]  Diane Solomon,et al.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. , 2007, American journal of obstetrics and gynecology.

[31]  Jason D. Wright,et al.  Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy , 2007, Cancer.

[32]  Natalie N. Braun,et al.  Radiation exposure and pregnancy: when should we be concerned? , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[33]  John Gosbee,et al.  ACR guidance document for safe MR practices: 2007. , 2007, AJR. American journal of roentgenology.

[34]  C. Holschneider,et al.  Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy , 2007, Nature Clinical Practice Oncology.

[35]  T. Herzog,et al.  A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. , 2007, Gynecologic oncology.

[36]  M. D. den Bakker,et al.  The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. , 2007, Gynecologic oncology.

[37]  G. del Priore,et al.  Abdominal Radical Trachelectomy During Pregnancy to Preserve Pregnancy and Fertility , 2006, Obstetrics and gynecology.

[38]  L. Lagae,et al.  Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature , 2004, International Journal of Gynecologic Cancer.

[39]  M. Plante,et al.  Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. , 2004, Gynecologic oncology.

[40]  D. Cella,et al.  Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  T. Dunn,et al.  Loop-cone cerclage in pregnancy: a 5-year review. , 2003, Gynecologic oncology.

[42]  K. Sakumoto,et al.  Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. , 2002, Gynecologic oncology.

[43]  G. Koliopoulos,et al.  Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[44]  A. Gruslin,et al.  Cervical cancer during pregnancy. , 2002, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[45]  C. Key,et al.  Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? , 2002, Gynecologic oncology.

[46]  B. Beaty,et al.  Management of the Minimally Abnormal Papanicolaou Smear in Pregnancy , 2001, Journal of lower genital tract disease.

[47]  V. Nicolet,et al.  MR imaging of cervical carcinoma: a practical staging approach. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[48]  F. Montz,et al.  Management of Stage I Cervical Cancer in Pregnancy , 2000, Obstetrical & gynecological survey.

[49]  D. McIntire,et al.  Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. , 1999, Obstetrics and gynecology.

[50]  J. Larghero,et al.  Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15-3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy. , 1998, Clinical chemistry.

[51]  Mangioni,et al.  Magnetic resonance imaging of cervical cancer in pregnancy , 1998 .

[52]  P. Disaia,et al.  The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. , 1998, American journal of obstetrics and gynecology.

[53]  R. Higgins,et al.  Management of low-grade squamous intraepithelial lesions during pregnancy. , 1997, American journal of obstetrics and gynecology.

[54]  G. Scambia,et al.  Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. , 1996, Gynecologic oncology.

[55]  D. Hodge,et al.  Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. , 1995, Gynecologic oncology.

[56]  G. Koren,et al.  Maternal and fetal outcome after invasive cervical cancer in pregnancy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  B. Sevin,et al.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.

[58]  Y. Touitou,et al.  Tumour marker antigens during menses and pregnancy. , 1989, British Journal of Cancer.

[59]  J. P. Palmer,et al.  Carcinoma of the cervix concomitant with pregnancy. , 1949, American journal of obstetrics and gynecology.

[60]  C. Haie-meder,et al.  Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging. , 2013, Clinical imaging.

[61]  S. Fosså,et al.  Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  T. Wright,et al.  2006 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia or Adenocarcinoma in Situ , 2008 .

[63]  T. Colgan,et al.  How important is removal of the parametrium at surgery for carcinoma of the cervix? , 2002, Gynecologic oncology.